We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $5.98B
1-Year Est. Return 80.99%
This Fund
S&P 500
This Quarter Est. Return
+21.26%
1 Year Est. Return
+80.99%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.97B
AUM Growth
+$710M
Cap. Flow
+$33.6M
Cap. Flow %
0.68%
Top 10 Hldgs %
43.85%
Holding
701
New
35
Increased
130
Reduced
246
Closed
41

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$31M
2
BTI icon
British American Tobacco
BTI
+$29.2M
3
SAP icon
SAP
SAP
+$27.1M
4
HOOD icon
Robinhood
HOOD
+$17.9M
5
CLS icon
Celestica
CLS
+$13.7M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$29.1M
2
TSM icon
TSMC
TSM
+$26.3M
3
META icon
Meta Platforms (Facebook)
META
+$23.5M
4
BEKE icon
KE Holdings
BEKE
+$22.1M
5
TCOM icon
Trip.com Group
TCOM
+$17M

Sector Composition

Rank Sector Weight
1 Technology 46.19%
2 Consumer Discretionary 14.25%
3 Communication Services 13.85%
4 Healthcare 7.17%
5 Consumer Staples 6.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SUPN icon
426
Supernus Pharmaceuticals
SUPN
$2.77B
$44.5K ﹤0.01%
1,413
– –
DEI icon
427
Douglas Emmett
DEI
$2.01B
$44.4K ﹤0.01%
2,954
-217
-7% -$3.14K
GRAL
428
GRAIL Inc
GRAL
$2.76B
$44.2K ﹤0.01%
860
– –
ADPT icon
429
Adaptive Biotechnologies
ADPT
$3.6B
$44K ﹤0.01%
3,779
– –
FOLD
430
DELISTED
Amicus Therapeutics
FOLD
$43.8K ﹤0.01%
7,651
– –
SPRY icon
431
ARS Pharmaceuticals
SPRY
$563M
$43.4K ﹤0.01%
2,488
– –
LXP icon
432
LXP Industrial Trust
LXP
$3.53B
$43.1K ﹤0.01%
1,043
-73
-7% -$3K
NAMS icon
433
NewAmsterdam Pharma
NAMS
$3.27B
$42.8K ﹤0.01%
2,365
– –
ARQT icon
434
Arcutis Biotherapeutics
ARQT
$3.55B
$42K ﹤0.01%
2,996
– –
SRPT icon
435
Sarepta Therapeutics
SRPT
$1.63B
$41.8K ﹤0.01%
2,446
– –
UE icon
436
Urban Edge Properties
UE
$2.92B
$41.4K ﹤0.01%
2,218
-147
-6% -$2.69K
NSA
437
DELISTED
National Storage Affiliates Trust
NSA
$41K ﹤0.01%
1,281
-91
-7% -$3.18K
IRON icon
438
Disc Medicine
IRON
$2.85B
$40.4K ﹤0.01%
762
– –
TARS icon
439
Tarsus Pharmaceuticals
TARS
$2.57B
$39.6K ﹤0.01%
978
– –
AKR icon
440
Acadia Realty Trust
AKR
$2.96B
$39.2K ﹤0.01%
2,113
-153
-7% -$2.96K
MPT
441
Medical Properties Trust
MPT
$2.89B
$38.8K ﹤0.01%
9,005
-1,230
-12% -$6.08K
VERA icon
442
Vera Therapeutics
VERA
$2.39B
$38.2K ﹤0.01%
1,621
– –
CURB
443
Curbline Properties
CURB
$3.61B
$38.1K ﹤0.01%
1,670
-121
-7% -$2.78K
IVT icon
444
InvenTrust Properties
IVT
$2.81B
$37.4K ﹤0.01%
1,366
-95
-7% -$2.64K
OCUL icon
445
Ocular Therapeutix
OCUL
$1.85B
$37.4K ﹤0.01%
4,026
– –
PK icon
446
Park Hotels & Resorts
PK
$3.06B
$36.4K ﹤0.01%
3,561
-358
-9% -$3.65K
BEAM icon
447
Beam Therapeutics
BEAM
$2.7B
$36.1K ﹤0.01%
2,120
– –
ANIP icon
448
ANI Pharmaceuticals
ANIP
$1.84B
$35.1K ﹤0.01%
538
– –
DVAX
449
DELISTED
Dynavax Technologies
DVAX
$33.4K ﹤0.01%
3,366
– –
TVTX icon
450
Travere Therapeutics
TVTX
$5.2B
$32.5K ﹤0.01%
2,198
– –
16 17
18
19 20

Similar funds

CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
BP
BC Partners New York $5.96B AUM 15.21% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $5.94B AUM 18.44% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.03B AUM 40.55% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
AL
Appaloosa LP Short Hills, New Jersey $5.93B AUM 44.55% 1-Year Est. Return
CGPCS
Capital Group Private Client Services Los Angeles, California $5.93B AUM 27.73% 1-Year Est. Return

GF Fund Management's Q2 2025 Portfolio in Review

As of Q2 2025, GF Fund Management held 701 positions worth $4.97B, up 17% from $4.26B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

GF Fund Management's Q2 2025 filing shows 35 new, 130 increased, 246 reduced and 41 closed positions. Its largest new stake was Shopify: 120,000 shares worth $13.8M. The largest sale was NVIDIA, an estimated $29.1M.

By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 42% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • GF Fund Management's largest Q2 2025 buy was Shopify: 120,000 shares worth $13.8M.
  • GF Fund Management added most to UnitedHealth in Q2 2025, an estimated $31M increase.
  • GF Fund Management's biggest Q2 2025 reduction was NVIDIA, cutting an estimated $29.1M.
  • GF Fund Management fully exited Salesforce in Q2 2025, selling an estimated $9.77M.
  • GF Fund Management's ten largest holdings make up 44% of its $4.97B portfolio in Q2 2025.
  • GF Fund Management opened 35 new positions and closed 41 in Q2 2025.
  • GF Fund Management's portfolio value rose 17% quarter-over-quarter to $4.97B.

Based on GF Fund Management's 13F filing for Q2 2025, filed 22 Jul 2025.